NCT03256916 2026-02-24
NELCER
Tata Memorial Hospital
Phase 3 Completed
Clinical Trials
9 trialsNCT05827523 2026-02-13
FOCUS / KOV-04
National Cancer Center, Korea
Phase 3 Recruiting
NCT06156514 2025-05-28
MICHELE
National Institute of Cancerología
Phase 3 Recruiting
NCT05910177 2024-03-06
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin
Fujian Cancer Hospital
Phase 2 Recruiting
NCT06066216 2024-01-23
Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT02957266 2016-11-15
CERVIPIB
The National Center of Oncology, Azerbaijan
Phase 3 Unknown
NCT02095119 2015-04-14
A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
National Institute of Cancerología
Phase 1/2 Completed
NCT00122772 2011-10-14
CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy
International Atomic Energy Agency
Phase 3 Completed
NCT00122746 2011-10-13
Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
International Atomic Energy Agency
Phase 3 Unknown